Merck & Co Inc (MRK)
99.85
+2.41
(+2.47%)
USD |
NYSE |
Nov 21, 16:00
99.92
+0.07
(+0.07%)
After-Hours: 17:51
Merck Debt to Equity Ratio: 0.8568 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.8568 |
| June 30, 2024 | 0.8671 |
| March 31, 2024 | 0.8478 |
| December 31, 2023 | 0.9328 |
| September 30, 2023 | 0.8451 |
| June 30, 2023 | 0.9539 |
| March 31, 2023 | 0.6565 |
| December 31, 2022 | 0.6673 |
| September 30, 2022 | 0.6842 |
| June 30, 2022 | 0.7322 |
| March 31, 2022 | 0.7777 |
| December 31, 2021 | 0.8669 |
| September 30, 2021 | 0.7387 |
| June 30, 2021 | 0.7966 |
| March 31, 2021 | 1.160 |
| December 31, 2020 | 1.256 |
| September 30, 2020 | 0.9848 |
| June 30, 2020 | 1.117 |
| March 31, 2020 | 1.068 |
| December 31, 2019 | 1.017 |
| September 30, 2019 | 0.9721 |
| June 30, 2019 | 0.9621 |
| March 31, 2019 | 0.9403 |
| December 31, 2018 | 0.9406 |
| September 30, 2018 | 0.7277 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.7175 |
| March 31, 2018 | 0.6997 |
| December 31, 2017 | 0.7109 |
| September 30, 2017 | 0.7058 |
| June 30, 2017 | 0.6306 |
| March 31, 2017 | 0.7148 |
| December 31, 2016 | 0.6197 |
| September 30, 2016 | 0.5748 |
| June 30, 2016 | 0.5601 |
| March 31, 2016 | 0.5883 |
| December 31, 2015 | 0.5912 |
| September 30, 2015 | 0.585 |
| June 30, 2015 | 0.5717 |
| March 31, 2015 | 0.633 |
| December 31, 2014 | 0.44 |
| September 30, 2014 | 0.6156 |
| June 30, 2014 | 0.477 |
| March 31, 2014 | 0.5632 |
| December 31, 2013 | 0.5036 |
| September 30, 2013 | 0.5614 |
| June 30, 2013 | 0.5917 |
| March 31, 2013 | 0.3927 |
| December 31, 2012 | 0.3879 |
| September 30, 2012 | 0.3516 |
| June 30, 2012 | 0.3439 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.6565
Minimum
Mar 2023
1.256
Maximum
Dec 2020
0.8913
Average
0.8619
Median
Debt to Equity Ratio Benchmarks
| Amgen Inc | 8.024 |
| Johnson & Johnson | 0.5096 |
| Eli Lilly and Co | 2.185 |
| Pfizer Inc | 0.7219 |
| Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 117.53B |
| Total Liabilities (Quarterly) | 72.97B |
| Shareholders Equity (Quarterly) | 44.50B |
| Current Ratio | 1.364 |
| Net Debt Paydown Yield | -0.08% |